Expanding the Clinical Phenotype with CD79A Mutation and Refractory Helicobacter Bilis Infection

Archan Sil,Suprit Basu,Kanika Arora,Raju Khubchandani,Amit Rawat,Deepti Suri
DOI: https://doi.org/10.1007/s10875-024-01792-9
IF: 8.542
2024-09-03
Journal of Clinical Immunology
Abstract:Autosomal recessive agammaglobulinemia is a severe primary antibody deficiency disorder typically presenting in infancy. We present a rare case of an 8-year-old boy with AR agammaglobulinemia due to a homozygous splice site variant (c.499-1G > A) in the CD79A gene. Despite monthly intravenous immunoglobulin replacement and prophylactic antibiotics, he developed refractory Helicobacter bilis leg ulcers. Helicobacter species are known for extracellular colonization and are challenging to culture, necessitating molecular diagnostics for identification. The patient required prolonged treatment with intravenous meropenem followed by oral metronidazole and doxycycline for resolution of the ulcers over two years. The patient also exhibited persistent asymptomatic thrombocytopenia, an atypical finding in CD79A mutation cases. This case underscores the importance of genetic diagnosis and targeted antimicrobial therapy in managing rare infections associated with primary immunodeficiencies like autosomal recessive agammaglobulinemia due to CD79A mutation.
immunology
What problem does this paper attempt to address?